Recently, the first NaV1.6 gain-of-function mutation associated with a human neuropathic pain disorder, trigeminal neuralgia, was reported27, highlighting the need to further investigate the role of NaV1.6 in the pain pathway. The gene discussed is SCN8A; the disease is trigeminal neuralgia.